News
During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences. Luellen shared the company's ambitious mission ...
The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Gilead Sciences, Inc.
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...
Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...
There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...
AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...
Apple is reportedly developing brain-computer interface technology to allow users to control devices with thoughts, enhancing ...
Op-ed views and opinions expressed are solely those of the author. Biotechadvancementsoftenfaceaysdue to bureaucracy, hindering the development of necessary therapies. Now is the time for us to […] ...
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...
The FDA plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...
Johns Hopkins University School of Medicine received a $10 million donation for an endowed AI center to further research and innovation in clinical and non-clinical spaces. There is rapid evolution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results